Category: News

All our news

ITCC-P4, first company in the world to offer preclinical drug tests for children with cancer

All our news

XenTech will attend AACR Annual Meeting in Orlando (Apr. 14-19 2023)

Philippe, Olivier and Delphine cordially invite you to stop by our Booth#618 to discuss our solid tumor PDX collection to bring your innovative research projects a step further !

Discover

All our news

XenTech will attend the World ADC London (Mar.- 13-16th)

Philippe and Olivier cordially invite you to stop by our Booth#12 to discuss our long experience in testing ADCs in our solid tumor PDX collection !

Discover

All our news

XenTech will attend the DDR inhibitors Summit 2023 (Boston, Jan. 24-26)

Our Head of R&D Oliver Déas will be delighted to discuss with you as he’ll be attending in person.

Discover

All our news

XenTech exhibits at EACR 2022 (Seville, Jun. 20-23 2022)

We’ll be exhibiting at EACR in Seville, stop by booth #50 !

Discover

All our news

XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)

We’ll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)

Discover

News

XenTech remains fully operational after 7 weeks of COVID-19 pandemic : update from our COO

In this 7th week of containment and as end of confinement in France is announced for May 11th, I would first of all like to thank you on behalf of our teams for all the messages of support you have sent us since the beginning of the COVID-19 crisis.

Discover

News

XenTech Covid-19 management

Regarding the current circumstances, we at XenTech want you to know that we are taking the Covid-19 pandemia very seriously. We are closely monitoring the pandemic, following guidance and advice from the World Health Organization (WHO), and the French Government.

Discover